The pen is mightier than the sword

Insulin

Volumn 4, Issue 3, 2009, Pages 132-135

  Shaefer Jr , Charles F ^a  

^a University Primary Care Physicians   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; PRAMLINTIDE;

ARTICLE; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG DELIVERY SYSTEM; DRUG SELF ADMINISTRATION; DRUG STORAGE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; SELF CARE; SHELF LIFE;

EID: 68649110530     PISSN: 15570843     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1557-0843(09)80027-4     Document Type: Article

References (21)

1. Bulwer-Lytton E. Richelieu; Or the Conspiracy. A Play in Five Acts. 2nd ed (1839), Saunders and Otley, London, UK
2. American Diabetes Association. Insulin pens. http://forecast.diabetes.org/files/images/InsulinPenChart.pdf Accessed May 1, 2009
3. Clarke A., and Spollett G. Dose accuracy and injection force dynamics of a novel disposable insulin pen. Expert Opin Drug Deliv. 4 (2007) 165-174
4. Lantus and Apidra [package insert] (May 2009), sanofi-aventis U.S. LLC, Bridgewater, NJ
5. Levemir [package insert] (October 2005), Novo Nordisk A/S, Bagsvaerd, Denmark
6. NovoLog Mix 70/30 [package insert] (June 2009), Novo Nordisk A/S, Bagsvaerd, Denmark
7. NovoLog [package insert] (June 2, 2009), Novo Nordisk A/S, Bagsvaerd, Denmark
8. Lilly prefilled pen instructions. http://medicalcenter.osu.edu/PatientEd/Materials/PDFDocs/medicatn/insulin-pens/lilly-insulin-pen.pdf Accessed May 1, 2009
9. Riddle M.C., Rosenstock J., Gerich J., and the Insulin Glargine 4002 Study Investigators. The treat-to-target trial: Randomized addition of glargine or human NPH to oral therapy of type 2 diabetic patients. Diabetes Care 26 (2003) 3080-3086
10. Holman R.R., Thorne K.I., Farmer A.J., et al., the 4-T Study Group. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med. 357 (2007) 1716-1730
11. Leahy J.L. Insulin management of diabetic patients on general medical and surgical floors. Endocr Pract. 12 Suppl 3 (2006) 86-90
12. Murray D.P., Keenan P., Gayer E., et al. A randomized trial of the efficacy and acceptability of a pen injector. Diabet Med. 5 (1988) 750-754
13. Stockl K., Ory C., Vanderplas A., et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin. 23 (2007) 133-146
14. Dornberger S., Stone D., and Elliott-Bynum S. Examining economic improvements in managing diabetes in the nursing home. Director. 7 (1999) 152-154
15. Dornberger S., Stone D., and Elliott-Bynum S. Examining economic improvements in managing diabetes in the nursing home. Director. 7 (1999) 157
16. Pawaskar M.D., Camacho F.T., Anderson R.T., et al. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: A retrospective database analysis. Clin Ther. 29 (2007) 1294-1305
17. Lee W.C., Balu S., Cobden D., et al. Medication adherence and associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data [published correction appears in Clin Ther. 2006;28:1968-1969]. Clin Ther. 28 (2006) 1968-1969 discussion 1710-1711
18. Hörnquist J.O., Wikby A., Andersson P.O., and Dufva A.M. Insulin-pen treatment, quality of life and metabolic control: Retrospective intra-group evaluations. Diabetes Res Clin Pract. 10 (1990) 221-230
19. Wikby A., Stenström U., Andersson P.O., and Hörnquist J. Metabolic control, quality of life, and negative life events: A longitudinal study of well-controlled and poorly regulated patients with type 1 diabetes after changeover to insulin pen treatment. Diabetes Educ. 24 (1998) 56-61
20. Wilk T., Mora P.F., Chaney S., and Shaw K. Use of an insulin pen by homeless patients with diabetes mellitus. J Am Acad Nurse Pract. 14 (2002) 372-379
21. Rubin R.R., and Peyrot M. Factors affecting the use of insulin pens by patients with type 2 diabetes. Diabetes Care. 31 (2008) 430-432